Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle
Author:
Funder
Marlene Harris-Ride Cincinnati Breast Cancer Foundation
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference41 articles.
1. Principles of nanoparticle design for overcoming biological barriers to drug delivery;Blanco;Nat. Biotechnol.,2015
2. Visualizing proteins and macromolecular complexes by negative stain EM: from grid preparation to image acquisition;Booth;J. Vis. Exp.,2011
3. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery;Cheng;Biomaterials,2007
4. Versatile RNA interference nanoplatform for systemic delivery of RNAs;Choi;ACS Nano,2014
5. Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery;Dehaini;Nanoscale,2016
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Polymeric nanoparticles as a promising platform for treating triple-negative breast cancer: Current status and future perspectives;International Journal of Pharmaceutics;2024-10
2. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment;Beni-Suef University Journal of Basic and Applied Sciences;2024-07-26
3. A holistic review of recent advances in nano-based drug delivery systems for the treatment of triple-negative breast cancer (TNBC);Journal of Nanoparticle Research;2024-05
4. Effect of MoS 2 on Simple and Novel PEG/κ-Carrageenan Hydrogels for TNBC Cancer Drug Delivery;Journal of Macromolecular Science, Part B;2024-04-09
5. Clinical Advances in Triple Negative Breast Cancer Treatment: Focus on Poly (L-lactide-coglycolide) Nanoparticles;Journal of Pharmacology and Experimental Therapeutics;2024-04-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3